Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 2,852 shares at $143.04 ($408K) on 2018-03-06, disclosed to the SEC on 2018-03-07.
Seasonal sale ($408k) by EVP & CFO — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.39 | 1,348 | $193K | 47.4% |
| 2 | $142.06 | 800 | $114K | 27.9% |
| 3 | $143.04 | 352 | $50K | 12.4% |
| 4 | $143.04 | 352 | $50K | 12.4% |
| Total | $142.93 avg | 2,852 | $408K | 100% |
| Filing → |
| JAZZ | SELL | 2018-11-27 | $105K | — | Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |